Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in Candida albicans Causing Ergosterol Biosynthesis Inhibition
Candida albicans is the most dominant and prevalent cause of fungal infections in humans. Azoles are considered as first-line drugs for the treatment of these infections. However, their prolonged and insistent use has led to multidrug resistance and treatment failures. To overcome this, modification...
Main Authors: | Ahmad, A. (Author), Asseri, A.H (Author), Rather, I.A (Author), Sabir, J.S.M (Author), Wani, M.Y (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans Isolates
by: Yi Xu, et al.
Published: (2017-11-01) -
Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills <i>Candida albicans</i>
by: Jakub Suchodolski, et al.
Published: (2021-05-01) -
Metabolic fitness of Candida albicans is indispensable for functional drug efflux, ergosterol, and chitin biosynthesis
by: Sandeep Hans, et al.
Published: (2020-09-01) -
The Multifunctional Fungal Ergosterol
by: Marcio L. Rodrigues
Published: (2018-09-01) -
Analysis of the ergosterol biosynthesis pathway cloning, molecular characterization and phylogeny of lanosterol 14α-demethylase (ERG11) gene of Moniliophthora perniciosa
by: Geruza de Oliveira Ceita, et al.
Published: (2014-12-01)